+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years +
MALE
ID07592299

Evaluating the ALPFA GRAIL Pulsed Field Ablation System Versus Sham Procedure for Treating Symptomatic Benign Prostatic Hyperplasia in Men

Led by ALPFA Medical · Updated on 2026-10-20

250

Participants Needed

1

Research Sites

269 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the ALPFA GRAIL Pulsed Field Ablation PFA System for treating urinary problems caused by benign prostatic hyperplasia BPH, or an enlarged prostate, in men over 40 years old. The study involves up to 250 male participants across centers in the US, Canada, and the European Union. It aims to test the safety and effectiveness of this device in relieving BPH symptoms through a randomized, controlled, and blinded design. Participants who meet eligibility criteria and have completed necessary medication washout will be randomly assigned to one of two groups. Two-thirds will receive treatment using the ALPFA GRAIL PFA System, which involves placing a catheter via a flexible cystoscope into the prostate to deliver pulsed field ablation. One-third will undergo a sham procedure using flexible cystoscopy without actual treatment. After 3 months, participants learn their group assignment those in the sham group may opt to receive treatment. Follow-up visits will continue for up to 5 years. During the study, participants will have health checks before and after treatment at 2 weeks, 4 weeks, 3 months, 6 months, and 12 months, then yearly up to 5 years. Researchers will measure safety through incidence of serious device- or procedure-related adverse events and assess effectiveness by changes in international prostate symptom scores at 3 and 12 months. Longer-term safety and durability of treatment effect will be monitored, with careful adherence to study procedures and medication restrictions.

CONDITIONS

Brief Title

To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate.

Research Team

E

Elizabeth Dravis

J

Jaya Kothule

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here